Brain Regions Involved in Fatigue Sensation: Reduced Acetylcarnitine Uptake into the Brain
暂无分享,去创建一个
Masao Iwase | Kouzi Yamaguti | Hirohiko Kuratsune | Yasuyoshi Watanabe | Gisela E. Hagberg | Hirotaka Onoe | Bengt Långström | Gudrun Lindh | Birgitta Evengård | Kiyoshi Matsumura | Mamoru Takahashi | Takashi Machii | Yuzuru Kanakura | Teruo Kitani | H. Onoe | B. Långström | M. Iwase | G. Hagberg | Y. Kanakura | Yasuyoshi Watanabe | B. Evengård | K. Yamaguti | H. Kuratsune | G. Lindh | T. Kitani | T. Machii | K. Matsumura | Mamoru Takahashi
[1] M. Raichle,et al. Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] D. Costa,et al. Brainstem perfusion is impaired in chronic fatigue syndrome. , 1995, QJM : monthly journal of the Association of Physicians.
[3] M. Schmidt,et al. The distribution and role of carnitine in the mammalian brain. , 1982, Life sciences.
[4] Kouzi Yamaguti,et al. Acylcarnitine and Chronic Fatigue Syndrome , 1997 .
[5] T Machii,et al. Acylcarnitine metabolism during fasting and after refeeding. , 1996, Biochemical and biophysical research communications.
[6] O Nickel,et al. Regional cerebral blood flow in depression: associations with psychopathology. , 1989, Journal of affective disorders.
[7] E. Meyer. Simultaneous correction for tracer arrival delay and dispersion in CBF measurements by the H215O autoradiographic method and dynamic PET. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] T. Greitz,et al. A computerized brain atlas: construction, anatomical content, and some applications. , 1991, Journal of computer assisted tomography.
[9] R Cluydts,et al. Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. , 1996, Neuropsychobiology.
[10] M. Raichle,et al. Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.
[11] R. Fariello,et al. Systemic acetyl-L-carnitine elevates nigral levels of glutathione and GABA. , 1988, Life sciences.
[12] R. Dolan,et al. Changes in regional cerebral blood flow on recovery from depression , 1995, Psychological Medicine.
[13] Karl J. Friston,et al. Tests for Distributed, Nonfocal Brain Activations , 1995, NeuroImage.
[14] Karl J. Friston,et al. Assessing the significance of focal activations using their spatial extent , 1994, Human brain mapping.
[15] B. Långström,et al. Synthesis of O-[11C]Acetyl CoA, O-[11C]Acetyl-L-carnitine, and L-[11C]carnitine labelled in specific positions, applied in PET studies on rhesus monkey. , 1997, Nuclear medicine and biology.
[16] W. Ammann,et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue , 1997, Neurology.
[17] F A Jolesz,et al. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. , 1994, AJR. American journal of roentgenology.
[18] Filippo Conti,et al. Effect of acetyl-l-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat — study by 13P- and 1H-NMR spectroscopy , 1994, Brain Research.
[19] J K Kelleher,et al. Role of Acetyl‐l‐Carnitine in Rat Brain Lipogenesis: Implications for Polyunsaturated Fatty Acid Biosynthesis , 1998, Journal of neurochemistry.
[20] G. Forloni,et al. Neuroprotective activity of acetyl‐L‐carnitine: Studies in vitro , 1994, Journal of neuroscience research.
[21] U. Tirelli,et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. , 1998, The American journal of medicine.
[22] C. Roe,et al. Maternal and fetal tissue distribution of L-carnitine in pregnant mice: low accumulation in the brain. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[23] William E. Klunk,et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease , 1995, Neurobiology of Aging.
[24] P. Fox,et al. Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.
[25] Stefano Calzolari,et al. Effect of acetyl-l-carnitine on hyperactivity and spatial memory deficits of rats exposed to neonatal anoxia , 1997, Neuroscience Letters.
[26] G Fiskum,et al. Neuroprotective effects of acetyl-L-carnitine after stroke in rats. , 1997, Annals of emergency medicine.
[27] T Machii,et al. High uptake of [2-11C]acetyl-L-carnitine into the brain: a PET study. , 1997, Biochemical and biophysical research communications.
[28] M Freedman,et al. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. , 1992, Nuclear medicine communications.
[29] T. Robbins,et al. The prefrontal cortex: Executive and cognitive functions. , 1998 .
[30] Luciano Angelucci,et al. Effect of acetyl-l-carnitine chronic treatment on discrimination models in aged rats , 1988, Physiology & Behavior.
[31] H. Misaki,et al. Acylcarnitine deficiency in chronic fatigue syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] T Machii,et al. Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. , 1998, International journal of molecular medicine.
[33] H. Onoe,et al. Brain Networks Affected by Synchronized Sleep Visualized by Positron Emission Tomography , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] V. Ganapathy,et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. , 1999, The Journal of pharmacology and experimental therapeutics.
[35] Ian Hickie,et al. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.
[36] I. Galynker,et al. Hypofrontality and negative symptoms in major depressive disorder. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] L L Bieber,et al. Entry of acetyl-L-carnitine into biosynthetic pathways. , 1986, Biochimica et biophysica acta.
[38] Karl J. Friston,et al. The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression , 1992, Psychological Medicine.